Our vision
Restoring balance through truth.
MaatFit is named for an ancient principle — balance, truth, order — because that is the actual work: to restore balance to metabolic medicine, using truth as the method.
Balance, restored through truth — better care for the patient, better leverage for the physician, better evidence for everyone.
Why we built MaatFit
The best treatment metabolic medicine has ever had arrived. And the field nearly broke under it.
For decades, chronic metabolic disease — obesity, type-2 diabetes, the whole cardio-metabolic cluster — was undertreated and under-resourced. Then came a generation of treatment that genuinely worked, and millions of people who had been waiting their whole lives walked through the door at once. The treatment scaled. The physicians did not.
The system did the only thing an overwhelmed system knows how to do: it made each unit of care smaller. The fifteen-minute visit became the norm. The three-month gap between visits became the norm. And in that gap, the field's oldest, quietest failure got worse. Most patients fall out of care before the treatment has time to work — not because they don't want to get better, but because nobody was watching closely enough, at the right moment, to catch them slipping.
We built MaatFit because we became convinced of two things at the same time. First: that the real scarcity in medicine was never effort, and it was never even physicians, exactly. It was attention — the continuous, careful noticing that good care requires and that no human can sustain across a thousand patients at once. Second: that for the first time, this was fixable. Capable clinical assistance had become affordable enough to give every patient continuous attention between visits.
Not to decide. To prepare. And when you put those two things together, the conclusion is unavoidable: you could build a system that lets a physician care for more people, keep them in care longer, and never lower the standard — if you built the whole thing as one system, and kept the physician in command of every decision. That system is MaatFit.
What we believe
The principles we won't compromise.
The physician belongs at the center of care — as the one who decides, not as a formality the software routes around.
Attention is the medicine. Most care fails in the silence between visits, and closing that silence is the highest-leverage thing software can do in chronic disease.
Retention is the whole game — keeping a person in care long enough to benefit is the hard, unglamorous, unsolved problem worth organizing a company around.
A patient is a person. Metabolic disease is a medical condition, not a moral failing. Dignity is the floor, not a feature.
Naming our limits matters. In medicine, the one who tells you what they can't do is the one you can trust.
Care should compound — every outcome should make the next decision better, and the evidence belongs to the field, not to a vendor's vault.
Humane and scalable are not opposites. Whoever proves they can coexist sets the pattern for how chronic care works for a generation.
Where this goes
The future metabolic medicine deserves.
Picture metabolic care a decade from now, if we get this right. A person diagnosed with metabolic disease doesn't enter a system that will see them for fifteen minutes and forget them for three months. They enter continuous care. Their physician sees their whole picture — not as a chart to reconstruct each visit, but as a living, assembled understanding that's always current.
The physician is not buried. They spend their time deciding and treating, because the gathering is done before they arrive. They can say yes to more patients without lying to themselves about the quality they can offer. The specialist shortage stops being a wall and becomes a slope — steep, but climbable, because each physician's judgment now reaches further than one pair of hands ever could.
And the field itself gets smarter. Every outcome, captured honestly, teaches the next decision. The questions that take a decade of fragmented studies to answer today start to have honest, accumulating answers — because for the first time the field has a continuous, longitudinal record of what actually happened. Not owned by a vendor. Earned by the care, in service of the field.
AI in healthcare
We hold an unfashionable view.
The breakthroughs that get attention are the dramatic ones — the model that diagnoses, the algorithm that beats the panel. The breakthroughs that change medicine are quieter: the continuous attention that catches the patient slipping, the preparation that gives a physician back their hours, the honest record that lets the field learn.
So we don't think the future of AI in healthcare is autonomous medicine, and we're not building toward it. We think it's affordable attention — the thing that was always too expensive to give every patient, now finally cheap enough to give everyone. That reframes AI from a replacement for the clinician into an amplifier — and it reframes the whole opportunity from how smart can the machine get to how much further can good human judgment reach.
The companies that matter in this era won't be the ones that claimed the most for their AI. They'll be the ones that were trusted with the most — and trust, in medicine, is earned by restraint, by keeping the human in command, by naming your limits, and by being right quietly for a long time.
We're preparing for early validation with US physician-led care and will begin opening access in stages.